p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium

Objectives Beryllium salts (here, beryllium sulphate) can produce a cytostatic effect in some cell types. The basis for this effect may include increased expression of proliferation inhibitors, reduced expression of proliferation promoters, or both. This study sought to determine the role of p53, th...

Full description

Saved in:
Bibliographic Details
Published in:Cell proliferation 2016-12, Vol.49 (6), p.698-709
Main Authors: Gorjala, P., Cairncross, J. G., Gary, R. K.
Format: Article
Language:English
Subjects:
Antineoplastic Agents - pharmacology
Beryllium - pharmacology
Brain - drug effects
Brain - metabolism
Brain Neoplasms - drug therapy
Brain Neoplasms - genetics
Cell Cycle - drug effects
Cell Line, Tumor
Cell Proliferation - drug effects
Cyclin-Dependent Kinase Inhibitor p21 - genetics
Cyclins - genetics
Cytostatic Agents - pharmacology
Down-Regulation - drug effects
Gene Expression Regulation, Neoplastic - drug effects
Glioblastoma - drug therapy
Glioblastoma - genetics
Humans
Original
RNA Interference
RNA, Messenger - genetics
RNA, Small Interfering - genetics
Tumor Suppressor Protein p53 - genetics
Up-Regulation - drug effects
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives Beryllium salts (here, beryllium sulphate) can produce a cytostatic effect in some cell types. The basis for this effect may include increased expression of proliferation inhibitors, reduced expression of proliferation promoters, or both. This study sought to determine the role of p53, the tumour‐suppressing transcription factor, in mediating beryllium‐induced cytostasis. Materials and methods Human A172 glioma cells express wild‐type TP53 gene. Activity of p53 was experimentally manipulated using siRNA and related approaches. Key elements of the beryllium‐response were compared in normal and p53‐knockdown A172 cells using RT‐PCR and Western blotting. Results In A172 cells, 10 μm BeSO4 caused 300% increase in CDKN1A (cyclin‐dependent kinase inhibitor p21) mRNA and 90% reduction of CCNE2 (cyclin E2) mRNA. The increased p21 mRNA and reduced cyclin E2 mRNA were each dependent on presence of functional p53. For p21, increased mRNA led to commensurately increased protein levels. In contrast, reduction in cyclin E2 mRNA levels did not lead to corresponding reductions in cyclin E2 protein. The proteasomal inhibitor MG‐132 caused p53 protein to increase, but it had no effect on cyclin E2 protein levels. Cycloheximide time course studies indicated that the cyclin E2 protein half‐life was more than 12 hours in these cells. Conclusions Beryllium elicited p53‐dependent changes in mRNA levels of key determinants of cell proliferation such as p21 and cyclin E2. However, cyclin E2 protein appeared to be aberrantly regulated in this cell type, as its turnover was unexpectedly slow.
ISSN:0960-7722
1365-2184
DOI:10.1111/cpr.12291